L04AJ Complement inhibitors Complement inhibitors Complement inhibitors Complement inhibitors L4
Source: Wikipedia · CC BY-SA 4.0 Fuente: Wikipedia · CC BY-SA 4.0 · nombre de respaldo (en) 来源:维基百科 · CC BY-SA 4.0 · 回退名 (en) 來源:維基百科 · CC BY-SA 4.0 · 回退名 (en)
ATC level L4 · Search this class · Consumer categories
Active ingredients in this class
12 active ingredients 12 principios activos 12 个活性成分 12 個有效成分
Each market now shows one aggregated status: a market counts as on sale if it has any active record; individual record statuses are shown in the details. The same market can also have several registration records with different statuses, so each market appears only once here; that is a record fact, not a safety judgement.
A missing name is marked in its row only when it is the exception; when most names lack it, the list stays unmarked.
- Eculizumab
L04AJ01active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES TW EU FR · unknown HK - Ravulizumab
L04AJ02active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES TW EU FR · unknown HK - Danicopan
L04AJ09active US GB CA SG ES · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA SG ES TW EU FR · unknown AU HK - Iptacopan
L04AJ08active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES TW EU FR · unknown HK - Avacopan
L04AJ05active US GB CA AU SG · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA AU SG CN FR · withdrawn ES EU - Zilucoplan
L04AJ06active US GB CA AU ES · and 3 more y 3 más 另有 3 个 另有 3 個
active US GB CA AU ES TW EU FR - Pegcetacoplan
L04AJ03active US GB CA AU ES · and 2 more y 2 más 另有 2 个 另有 2 個
active US GB CA AU ES EU FR - Crovalimab
L04AJ07active US GB CA ES TW · and 1 more y 1 más 另有 1 个 另有 1 個
active US GB CA ES TW EU - Sutimlimab
L04AJ04active US ES EU FR
active US ES EU FR - Vilobelimab
L04AJ10active US EU
active US EU - 盐酸伊普可泮
L04AJactive CN
active CN - Pozelimab
L04AJ11active US
active US
By dosage form, across markets
Only ingredients with a recorded ATC class are listed (6,009 of 12,637).